Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating gonadotropin concentration (HP:0030338)help
Grandparent Node:
expand
Hyperpituitarism (HP:0010514)help
Parent Node:
expand
Abnormal circulating luteinizing hormone concentration (HP:0030345)help
Parent Node:
expand
Increased circulating gonadotropin level (HP:0000837)help
..Starting node
..expand
Elevated circulating luteinizing hormone level (HP:0011969)help
Term ID: 11969
Name: Elevated circulating luteinizing hormone level
Synonym: Elevated LH level; Elevated luteinizing hormone; Increased circulating luteinizing hormone level
Definition: An elevated concentration of luteinizing hormone in the blood.
Comments:
Reference: HP:0011969
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandElevated circulating follicle stimulating hormone level (HP:0008232) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0AR CL E G H367644OMIM:300068Androgen insensitivity syndrome.125
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8.
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28.107
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040283 - Occasional92
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 14.2
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0KISS1R CL E G H846344510OMIM:176400Precocious puberty, central.14
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 10.4
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0MSH4 CL E G H44387327OMIM:619938
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 10.2
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040283 - Occasional76
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy.
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0SRY CL E G H673611311OMIM:40004546XX sex reversal 1.23
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0SRY CL E G H673611311OMIM:40004446XY sex reversal 1.23
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0011969HP:0011969Elevated circulating luteinizing hormone level0ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10


Genes (38) :AR BMPR1B C14ORF39 CYB5A CYP11A1 CYP17A1 DHX37 DIAPH2 DMRT3 ESR2 FANCM FGD1 FIGLA FOXL2 FSHB GATA4 GCNA GDF9 KISS1R MAP3K1 MCM8 MSH4 NR0B1 NR5A1 NSMCE2 POR PPP2R3C PSMC3IP SOX9 SPIDR SRY STAG3 VAMP7 WT1 WWOX XRCC2 ZFPM2 ZSWIM7

Diseases (35) :OMIM:300068 ORPHA:99429 ORPHA:90797 OMIM:609441 OMIM:619203 ORPHA:90796 ORPHA:168558 ORPHA:289548 ORPHA:90793 OMIM:273250 ORPHA:251510 OMIM:300511 OMIM:618187 OMIM:618086 OMIM:305400 OMIM:612310 ORPHA:572333 OMIM:229070 OMIM:301077 OMIM:618014 OMIM:176400 OMIM:612885 OMIM:619938 OMIM:612965 OMIM:612964 OMIM:617253 ORPHA:95699 OMIM:618419 OMIM:614324 OMIM:619665 OMIM:400045 OMIM:400044 OMIM:615723 OMIM:619146 OMIM:619834
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.